UnitedHealth Group Incorporated (UNH) Stock: Price, Forecast & Analyst Target
UnitedHealth Group Incorporated (UNH) — MoonshotScore 75/100 (Strong band), calculated Oct 8, 2026. Price $370.75 (-1.39%), as of the Oct 8, 2026 trading session; market cap $337B. Expected results Oct 13, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 10.71× (market value Oct 8, 2026; cash Jun 30, 2026) · expected results Oct 13, 2026
UnitedHealth Group Incorporated · UNH · NYSE · Healthcare · Medical - Healthcare Plans
Research dated 2026-09-13: UnitedHealth is an integrated health-care platform: UnitedHealthcare provides health benefits, while Optum delivers care, administers pharmacy benefits, and sells technology and services to health systems, payers, governments, and life-sciences companies. The case depends on whether demand across that network can again produce durable profit as medical utilization and membership mix pressure insurance economics.
Price as of Oct 8, 2026
Key Statistics
MoonshotScore v2 · UnitedHealth Group (UNH)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality, at a cheap price, though the balance sheet and growth are only middling; the market is already moving on it. Business Quality: Elite; Financial Safety: Okay; Valuation: Cheap; Growth Durability: Flat; Momentum: Rising.
- quarterly revenue $112.03B (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 5 of 8
- expected results Oct 13, 2026
Helping: business quality, an attractive price, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 75 | Strong | |
| 75 | Strong | |
| 75 | Strong | |
| 75 | Strong | |
| 76 | Strong | |
| 74 | Strong |
The score moved from 74 in the stored Oct 7, 2026 snapshot to 75 in the current publication computed Oct 8, 2026 (+1); the largest pillar moves were Momentum +1. This current publication is not yet represented in the immutable snapshot archive.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $370.75 | |
| Change on the day | -1.39% | |
| 52-week range | $255.97–$461.62 | |
| Market capitalisation | $337B | |
| Price / earnings (trailing) | 24.18 | |
| Shares traded on the day | 3.34M | |
| Beta (volatility vs the S&P 500) | 0.62 | |
| Dividends per share (last 12 months) | $9.06 | |
| Dividend yield (last 12 months) | 2.41% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings call · management outlook
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Management outlook
As you saw earlier this morning, we have updated our full year 2026 guidance to reflect performance through the first half of the year and a more mature understanding of expected membership mix and utilization patterns for the remaining six months. We continue to be respectful of medical trend, and we believe this refreshed outlook appropriately balances risk and investments with durable run rate earnings.
Wayne DeVeydt · Statement from
We now expect to complete total share repurchases of at least $5 billion in 2026, compared to initial guidance of $2.5 billion.
Wayne DeVeydt · Statement from
Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.
Read management statementsCouncil Score · weighted blend of 2 available disciplines
Council score for UnitedHealth Group (UNH): Bullish Lean
62/100 · B+Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
5 lenses, 5 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 7, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
Two of these lenses read this company less favourably than the MoonshotScore does: Englander-style lens and Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
On Sep 10, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Oct 9, 2026, except a card that shows its own read date.
Watch the UNH film — every key number, told as a short cinematic story
~2 min · open the film
What is UnitedHealth Group (UNH), and what does it report?
Short answer · as of
UnitedHealthcare sells health-benefit plans to employers, public programs, and individuals.
Research dated 2026-09-13.
UnitedHealthcare sells health-benefit plans to employers, public programs, and individuals. Optum Health earns from care delivery and management, Optum Insight from software, information, consulting, and managed services, and Optum Rx from pharmacy-benefit administration, prescription delivery, and specialty pharmacy capabilities.
Reported revenue therefore combines health-plan activity with care, pharmacy, technology, and service activity. UnitedHealthcare dominates the disclosed segment figures, but consolidated margins reflect the economics of the wider group rather than those of a standalone insurer.
What do the latest results show for UnitedHealth Group (UNH)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $112.03B.
Research dated 2026-09-13.
Revenue was broadly steady in the latest period, while operating profit, net income, and diluted earnings softened from the immediately preceding period. Even so, the latest reported revenue and earnings exceeded market expectations, and profitability remained far above the severe year-end trough.
The longer pattern is less comfortable: annual revenue continued to expand while net income declined again. Management attributes the revised outlook to a more developed view of membership mix and medical utilization, while also expecting operating costs to reflect investment in people, communities, and artificial intelligence.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $112.03B Jun 30, 2026
- Latest quarter · SG&A
- $0.00 Jun 30, 2026
- Latest quarter · FMP standardized operating result
- $7.99B Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $112.03B | Not available | $0.00 | $7.99B |
| Mar 31, 2026 | $111.72B | Not available | $15.39B | $8.99B |
| Dec 31, 2025 | $113.22B | Not available | $0.00 | $380.00M |
| Sep 30, 2025 | $113.16B | Not available | $0.00 | $4.32B |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $112.03B Jul 16, 2026
- Latest report · revenue estimate
- $110.81B Jul 16, 2026
- Latest report · revenue vs estimate
- Above estimate Jul 16, 2026
- Latest report · EPS vs estimate
- Above estimate Jul 16, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Jul 16, 2026 | $112.03B | $110.81B | $6.3800 | $4.9400 |
| Apr 21, 2026 | $112.03B | $109.43B | $7.2300 | $6.4600 |
| Jan 27, 2026 | $113.22B | $113.77B | $2.1100 | $2.1000 |
| Oct 28, 2025 | $113.16B | $113.03B | $2.9200 | $2.8000 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $112.03B | $5.48B | $6.05 (diluted) |
| Q1 FY2026 | $111.72B | $6.28B | $6.90 (diluted) |
| Q4 FY2025 | $113.22B | $10M | $0.01 (diluted) |
| Q3 FY2025 | $113.16B | $2.35B | $2.59 (diluted) |
What are the financial strengths and risks for UnitedHealth Group (UNH)?
Short answer
Cash and short-term investments were $31.47B at the Jun 30, 2026 balance-sheet date. Operating cash flow was $11.05B for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Operating cash generation strengthened markedly in the latest periods, with capital spending absorbing only a modest share of the inflow. Cash and short-term investments also recovered from the year-end level, although they remain below the opening level of the reported history and below total debt.
Including long-term investments puts cash and investments above debt, but those investments carry an unclassified designation and should not be treated as equivalent to immediately available cash. Short-term coverage remains below parity, net margins are thin, and the main operating risk is that medical costs rise faster than pricing and efficiency measures can absorb them.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $11.05B Jun 30, 2026
- Previous quarter · operating cash flow
- $8.91B Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | $11.05B | −$799.00M |
| Mar 31, 2026 | $8.91B | −$763.00M |
| Dec 31, 2025 | $1.11B | −$948.00M |
| Sep 30, 2025 | $5.95B | −$890.00M |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at UnitedHealth Group (UNH)?
Short answer · as of
The next earnings report is expected on Oct 13, 2026.
Research dated 2026-09-13.
Medical utilization, membership mix, and the medical care ratio deserve the closest attention because management tied its refreshed outlook directly to those variables. The next result should also reveal whether operating costs associated with current investments are being offset elsewhere in the organization.
Revenue expectations sit near the recent quarterly run rate, while expected earnings are below the latest reported result. A constructive operating signal would be steadier profit at that revenue level without deterioration in cash conversion; renewed margin compression would keep the annual profit decline unresolved.
Higher planned share repurchases add another checkpoint. Cash generation must continue to support capital returns without making the gap between readily available cash and debt more demanding.
What management is planning
Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.
As you saw earlier this morning, we have updated our full year 2026 guidance to reflect performance through the first half of the year and a more mature understanding of expected membership mix and utilization patterns for the remaining six months. We continue to be respectful of medical trend, and we believe this refreshed outlook appropriately balances risk and investments with durable run rate earnings.
Wayne DeVeydt ·
We now expect to complete total share repurchases of at least $5 billion in 2026, compared to initial guidance of $2.5 billion.
Wayne DeVeydt ·
We now expect a full-year medical care ratio of 88.1% ± 25 basis points. We expect the operating cost ratio to come in at the higher end of our previously discussed range as a result of investments in our people, communities, and AI.
Wayne DeVeydt ·
How does UnitedHealth Group compare with its peers?
Short answer
UnitedHealth Group's score ranks tied for 7th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
UnitedHealth differs from a standalone health insurer because it participates in benefit design, direct care, pharmacy management, and the technology and services used by other health-care organizations. That breadth creates several sources of revenue, but it also means earnings depend on medical claims, care-delivery execution, prescription economics, and service operations at the same time.
UnitedHealthcare remains the financial center of gravity in the disclosed segment figures. Optum changes the nature of the comparison: peers focused only on underwriting do not carry the same combination of provider, pharmacy, and health-care infrastructure exposure.
| Company | Price | Market value | Score |
|---|---|---|---|
| $33.10 Oct 8, 2026 | $8.53B | 95 5-pillar Oct 8, 2026 | |
| $38.18 Oct 8, 2026 | $170B | 91 5-pillar Oct 8, 2026 | |
| $400.94 Oct 8, 2026 | $87.0B | 89 5-pillar Oct 8, 2026 | |
| $158.78 Oct 8, 2026 | $245B | 86 5-pillar Oct 8, 2026 | |
| $143.11 Oct 8, 2026 | $272B | 84 5-pillar Oct 8, 2026 | |
| $281.03 Oct 8, 2026 | $74.1B | 82 5-pillar Oct 8, 2026 | |
| UnitedHealth Group (UNH) — this page | $370.75 | $337B | 75 |
| $142.40 Oct 8, 2026 | $352B | 75 5-pillar Oct 8, 2026 | |
| $98.49 Oct 8, 2026 | $170B | 71 5-pillar Oct 8, 2026 | |
| $64.54 Oct 8, 2026 | $31.9B | 71 5-pillar Oct 8, 2026 | |
| $8.71 Oct 8, 2026 | $1.81B | 71 5-pillar Oct 8, 2026 | |
| $87.80 Oct 8, 2026 | $112B | 69 5-pillar Oct 8, 2026 | |
| $195.85 Oct 8, 2026 | $10.2B | 64 5-pillar Oct 8, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $373.00 – $529.00
- Consensus target
- $473.89
- Median target
- $491.00
Consensus record · Captured .
Measured against a quoted price of $370.75 (as of Oct 8, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Oct 1, 2026
- Transactions
- 56
- Identified insiders
- 15
- Purchases
- 0
- Sales
- 3
- Other transactions
- 53
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Institutional ownership
- 88.5% Period end Jun 30, 2026
- Previous quarter · ownership
- 82.2% Prior to period end Jun 30, 2026
- Reporting holders
- 3,563 Period end Jun 30, 2026
- Previous quarter · holders
- 3,217 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 76,863,061 |
| Vanguard Capital Management LLC | 59,311,525 |
| State Street Corp | 45,633,267 |
| Capital World Investors | 29,887,932 |
| Fmr LLC | 27,992,995 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about UnitedHealth Group (UNH)?
What Investors Ask About UnitedHealth Group (UNH) — Healthcare
Research dated 2026-09-13; the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
How do UnitedHealthcare and Optum fit together?
UnitedHealthcare provides health benefits, while Optum delivers care and supplies pharmacy, technology, consulting, and managed services. Their combination makes UnitedHealth dependent on more than premium growth and claims experience alone.
Why did UnitedHealth revenue growth fail to protect annual profit?
Revenue kept expanding while net income declined again, showing that added volume did not translate proportionately into earnings. Management has identified medical utilization, membership mix, and higher operating investment as pressures requiring close attention.
Why is Optum Rx important to UnitedHealth's model?
Optum Rx manages pharmacy networks, home delivery, specialty pharmacy, formularies, and medication programs. It gives UnitedHealth exposure to prescription administration and pharmacy economics alongside insurance and care delivery.
Can UnitedHealth support buybacks and dividends alongside its debt?
Recent operating cash flow provides substantial capacity for capital returns, and management increased its repurchase plan while dividends continued. Debt still exceeds cash and short-term investments, so sustained cash conversion matters more than the headline cash balance alone.
What is the UNH stock price today?
The last price recorded on this page for UnitedHealth Group Incorporated (UNH) is $370.75, as of the Oct 8, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the UNH price target?
The analyst consensus price target for UnitedHealth Group Incorporated (UNH) is $473.89 (range $373.00 to $529.00, median $491.00), per FMP data captured Oct 8, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
When are UNH's next earnings?
The next earnings date listed on this page for UnitedHealth Group Incorporated (UNH) is Oct 13, 2026. Companies sometimes move report dates, so the company's own announcement is the final word on timing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (80 figures)
The 80 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 2 facts from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
prod.outlook | Management outlook — call excerpts | Wayne DeVeydt (Jul 16, 2026): As you saw earlier this morning, we have updated our full year 2026 guidance to reflect performance through the first half of the year and a more mature understanding of expected membership mix and utilization patterns for the remaining six months. We continue to be respectful of medical trend, and we believe this refreshed outlook appropriately balances risk and investments with durable run rate earnings. Wayne DeVeydt (Jul 16, 2026): We now expect to complete total share repurchases of at least $5 billion in 2026, compared to initial guidance of $2.5 billion. Wayne DeVeydt (Jul 16, 2026): We now expect a full-year medical care ratio of 88.1% ± 25 basis points. We expect the operating cost ratio to come in at the higher end of our previously discussed range as a result of investments in our people, communities, and AI. | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | |
id.hq | SEC filing business address | Eden Prairie, MN | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "1 Health Drive, Eden Prairie, MN, 55344, US". The FMP company description names Minnetonka, Minnesota as the headquarters; this page uses the address in this row. |
FMP — 69 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $370.75 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-08T20:05:14.411Z. | |
px.change | Change on the day | -1.39% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $337B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-08. FMP quote timestamp: 2026-10-08T19:59:59.000Z. Captured from FMP at 2026-10-08T20:05:13.422Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | −$5.23 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $112.03B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.range52 | 52-week range | $255.97–$461.62 | FMP | Financial Modeling Prep (FMP) quote | |
px.pe | Price / earnings (trailing) | 24.18 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 3.34M | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.62 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Stephen J. Hemsley | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 390,000 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2021 through FY2025: FY2021 revenue $287.60B, net result $17.29B; FY2022 revenue $324.16B, net result $20.12B; FY2023 revenue $371.62B, net result $22.38B; FY2024 revenue $400.28B, net result $14.40B; FY2025 revenue $447.57B, net result $12.06B | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.rev_mix | Reported revenue segments | Premiums $352.23B · Products $53.38B · Services $38.04B · Investment and other income $3.92B | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K | |
fin.gross_margin | Gross margin (trailing twelve months) | 22.5% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table.depth.2026-06-30.revenue_k | Revenue — period end 2026-06-30 | $112.03B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.sga_k | SG&A — period end 2026-06-30 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.operating_result_k | FMP standardized operating result — period end 2026-06-30 | $7.99B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.revenue_k | Revenue — period end 2026-03-31 | $111.72B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.sga_k | SG&A — period end 2026-03-31 | $15.39B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.operating_result_k | FMP standardized operating result — period end 2026-03-31 | $8.99B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.revenue_k | Revenue — period end 2025-12-31 | $113.22B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.sga_k | SG&A — period end 2025-12-31 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.operating_result_k | FMP standardized operating result — period end 2025-12-31 | $380.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.revenue_k | Revenue — period end 2025-09-30 | $113.16B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.sga_k | SG&A — period end 2025-09-30 | $0.00 | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.operating_result_k | FMP standardized operating result — period end 2025-09-30 | $4.32B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
earn.history.depth.2026-07-16.revenue_actual | Revenue · reported — report date 2026-07-16 | $112.03B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-16.revenue_estimated | Revenue · estimate — report date 2026-07-16 | $110.81B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-16.eps_actual | EPS · reported — report date 2026-07-16 | $6.3800 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-07-16.eps_estimated | EPS · estimate — report date 2026-07-16 | $4.9400 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-21.revenue_actual | Revenue · reported — report date 2026-04-21 | $112.03B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-21.revenue_estimated | Revenue · estimate — report date 2026-04-21 | $109.43B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-21.eps_actual | EPS · reported — report date 2026-04-21 | $7.2300 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-04-21.eps_estimated | EPS · estimate — report date 2026-04-21 | $6.4600 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.revenue_actual | Revenue · reported — report date 2026-01-27 | $113.22B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.revenue_estimated | Revenue · estimate — report date 2026-01-27 | $113.77B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.eps_actual | EPS · reported — report date 2026-01-27 | $2.1100 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-01-27.eps_estimated | EPS · estimate — report date 2026-01-27 | $2.1000 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-28.revenue_actual | Revenue · reported — report date 2025-10-28 | $113.16B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-28.revenue_estimated | Revenue · estimate — report date 2025-10-28 | $113.03B | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-28.eps_actual | EPS · reported — report date 2025-10-28 | $2.9200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-10-28.eps_estimated | EPS · estimate — report date 2025-10-28 | $2.8000 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $31.47B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. | |
fin.opcf_latest | Latest-quarter operating cash flow | $11.05B | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.long_term_investments | Long-term investments (classification unverified) | $57.72B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.total_debt | Total debt | $73.33B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.price_to_book | Price to book value | 3.46× | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.opcf.depth.2026-06-30.operating_cash_flow_m | Operating cash flow — period end 2026-06-30 | $11.05B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.operating_cash_flow_m | Operating cash flow — period end 2026-03-31 | $8.91B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-06-30.capex_m | Capital expenditure (reported) — period end 2026-06-30 | −$799.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.capex_m | Capital expenditure (reported) — period end 2026-03-31 | −$763.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.operating_cash_flow_m | Operating cash flow — period end 2025-12-31 | $1.11B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.capex_m | Capital expenditure (reported) — period end 2025-12-31 | −$948.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.operating_cash_flow_m | Operating cash flow — period end 2025-09-30 | $5.95B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.capex_m | Capital expenditure (reported) — period end 2025-09-30 | −$890.00M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
earn.pt_range | Analyst price target, low to high | $373.00 – $529.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 8, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $473.89 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 8, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $491.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 8, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 56 transactions · 0 purchases, 3 sales, 53 other transactions · 15 identified insiders · of the newest 100 records, those within the last 180 days, newest dated Oct 1, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. | |
own.institutions.depth.ownership_pct | Institutional ownership | 88.5% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.ownership_pct_previous_quarter | Previous quarter · ownership | 82.2% | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.institutions.depth.holders | Reporting holders | 3,563 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 3,217 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Blackrock, INC. — shares in provider snapshot | 76,863,061 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Vanguard Capital Management LLC — shares in provider snapshot | 59,311,525 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | State Street Corp — shares in provider snapshot | 45,633,267 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | Capital World Investors — shares in provider snapshot | 29,887,932 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Fmr LLC — shares in provider snapshot | 27,992,995 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 2 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Oct 13, 2026 | UNRECORDED | Stored earnings-calendar observation — Captured 2026-09-30 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 5 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-09-18 · Expired observation |
COMPUTED — 5 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.mcap_to_cash | Market value per dollar of cash and short-term investments | 10.71× | — | COMPUTED | Computed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $31.47B at Jun 30, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-08. Balance-sheet reference date: 2026-06-30. The inputs do not establish a single common source date for this ratio. |
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $9.06 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 4 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-08, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 2.41% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-07-16.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($112.03B) with the recorded estimate ($110.81B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-07-16.eps_actual.comparison | Latest report · EPS vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($6.3800) with the recorded estimate ($4.9400) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 75 of 100 · Strong · pillars 81 / 50 / 83 / 45 / 71 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 74 (stored snapshot Oct 7, 2026) → 75 (current publication computed Oct 8, 2026) (+1) | OURS | Stock Expert AI current score publication and immutable score snapshots — The current score publication is not yet represented in the immutable snapshot archive. |
Fact-family notes
- Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-06-30.revenue_k,fin.q_table.depth.2026-06-30.sga_k,fin.q_table.depth.2026-06-30.operating_result_k,fin.q_table.depth.2026-03-31.revenue_k,fin.q_table.depth.2026-03-31.sga_k,fin.q_table.depth.2026-03-31.operating_result_k,fin.q_table.depth.2025-12-31.revenue_k,fin.q_table.depth.2025-12-31.sga_k,fin.q_table.depth.2025-12-31.operating_result_k,fin.q_table.depth.2025-09-30.revenue_k,fin.q_table.depth.2025-09-30.sga_k,fin.q_table.depth.2025-09-30.operating_result_k. - Earnings-history note. Source series as of 2026-07-16. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-07-16.revenue_actual,earn.history.depth.2026-07-16.revenue_estimated,earn.history.depth.2026-07-16.revenue_actual.comparison,earn.history.depth.2026-07-16.eps_actual.comparison,earn.history.depth.2026-07-16.eps_actual,earn.history.depth.2026-07-16.eps_estimated,earn.history.depth.2026-04-21.revenue_actual,earn.history.depth.2026-04-21.revenue_estimated,earn.history.depth.2026-04-21.eps_actual,earn.history.depth.2026-04-21.eps_estimated,earn.history.depth.2026-01-27.revenue_actual,earn.history.depth.2026-01-27.revenue_estimated,earn.history.depth.2026-01-27.eps_actual,earn.history.depth.2026-01-27.eps_estimated,earn.history.depth.2025-10-28.revenue_actual,earn.history.depth.2025-10-28.revenue_estimated,earn.history.depth.2025-10-28.eps_actual,earn.history.depth.2025-10-28.eps_estimated. - Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-06-30.operating_cash_flow_m,fin.opcf.depth.2026-03-31.operating_cash_flow_m,fin.opcf.depth.2026-06-30.capex_m,fin.opcf.depth.2026-03-31.capex_m,fin.opcf.depth.2025-12-31.operating_cash_flow_m,fin.opcf.depth.2025-12-31.capex_m,fin.opcf.depth.2025-09-30.operating_cash_flow_m,fin.opcf.depth.2025-09-30.capex_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Optumhealth: $19.84B; Unitedhealthcare: $332.39B | 2025-12-31 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2025-12-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Management outlook — dated call excerpts | Captured record · 3 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-07-16 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
| Sector / industry (provider taxonomy) | Healthcare / Medical - Healthcare Plans The company's SEC filings classify it under SIC 6324 — Hospital & Medical Service Plans. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Trailing twelve-month ratio set | Quick ratio: 0.78; Current ratio: 0.78; Debt to equity: 0.74; Net margin: 3.1%; Gross margin: 22.5%; Operating margin: 4.8%; Return on assets: 4.6%; Return on equity: 14.6% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-07-16 | FMP | Financial Modeling Prep (FMP) earnings |
| Most recent periodic reports | 2026-08-10 | OFFICIAL | SEC EDGAR filer submissions | |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Cash, investments and debt | Total debt: $73.33B; Liquidity basis: cash and short-term investments; Total liabilities: $205.11B; Cash and short-term investments: $31.47B; Cash and investments: $89.18B; Long-term investments: $57.72B; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $89.18B; Cash and short-term investments: $31.47B; Long-term investments: $57.72B; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-06-30 | COMPUTED | Computed from the balance sheet |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Cash decline over the reported window | To: 2026-06-30; From: 2024-09-30; Periods: 7; Cash basis: cash and short-term investments; Closing balance: $31.47B; Decline: $5.67B; Opening balance: $37.13B; Average change per period: $809.40M Change in cash, cash equivalents and short-term investments between the 2024-09-30 and 2026-06-30 balance sheets.; This is a balance change, not operating burn: financing and investing move it too.; Averaged over 7 reporting periods of unequal length. | 2026-06-30 | COMPUTED | Computed from reported balances |
| Cash against market value | As of: 2026-06-30; Cash basis: cash and short-term investments; Net cash: -$41.86B; Total debt: $73.33B; Cash and investments: $31.47B Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them. | 2026-06-30 | COMPUTED | Computed from the balance sheet and the latest market capitalization |
| Distress and quality screens | Altman Z-score: 3.05; Piotroski F-score: 8 Altman Z below 1.8 is the conventional distress zone. The screen is built for manufacturers and industrials; for banks, insurers and property companies it is not a meaningful reading. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) financial scores |
| Next earnings report | Date: 2026-10-27; EPS estimate: $4.09 per share; Revenue estimate: $111.31B The date is our provider's estimate until the company confirms it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) earnings calendar |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-13 | FMP | Financial Modeling Prep (FMP) analyst estimates |
| Recent dividends paid | Captured record · 4 entries
Declared amounts per share on their ex-dates. A single payment does not establish an annual rate, and a special dividend is not separated here. | 2026-06-15 | FMP | Financial Modeling Prep (FMP) dividend history |
| Next scheduled dividend | Ex date: 2026-09-14; Declared on: 2026-08-11; Record date: 2026-09-14; Payment date: 2026-09-22; Amount per share: $2.32 Amount is per share as declared, before any withholding. Owning the share before the ex-date is what carries entitlement. | 2026-08-11 | FMP | Financial Modeling Prep (FMP) dividend calendar |
Data provided for informational purposes only.
ETFs that hold UNH
Funds in our ETF coverage that list UNH among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.